Meiji Yasuda Asset Management Co Ltd. bought a new position in Corteva, Inc. (NYSE:CTVA – Free Report) in the second quarter, according to its most recent filing with the SEC. The firm bought 10,687 shares of the company’s stock, valued at approximately $905,000.
Several other large investors have also added to or reduced their stakes in the company. William B. Walkup & Associates Inc. boosted its holdings in Corteva by 2.9% during the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock worth $373,000 after buying an additional 126 shares in the last quarter. Wilkerson Advisory Group LLC increased its position in shares of Corteva by 6.7% during the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after purchasing an additional 133 shares in the last quarter. AdvisorNet Financial Inc grew its holdings in shares of Corteva by 2.4% during the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after buying an additional 135 shares in the last quarter. First Horizon Corp grew its stake in Corteva by 9.2% during the 1st quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after acquiring an additional 135 shares in the last quarter. Finally, Aviance Capital Partners LLC increased its holdings in shares of Corteva by 1.3% in the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after purchasing an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Corteva Trading Up 0.4%
CTVA opened at $83.18 on Wednesday. The business’s 50 day moving average is $82.39 and its two-hundred day moving average is $80.37. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97. The firm has a market cap of $55.50 billion, a price-to-earnings ratio of 55.09, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Rothschild & Co Redburn raised their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. JPMorgan Chase & Co. increased their target price on Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. CICC Research upped their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Finally, Bank of America raised their target price on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.
Get Our Latest Stock Report on Corteva
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
